·HANQUYOU is poised to be the first Chinese monoclonal antibody to enter the Middle Eastern market, further expanding its global presence.·HANQUYOU was approved in more than 40 countries and regions around the world.·With the first shipment to the Middle East, Henlius has realized commercialized supply across China, Europe, Southeast Asia, Latin America,&#

On 4 June 2024,Lisbon, Portugal, Chinese Minister of Commerce Wang Wentao chaired a roundtable with representatives from Chinese enterprises operating in Portugal. Representatives from Chinese enterprises engaged in sectors such as energy, finance, construction, and telecommunications in Portugal attended the roundtable, during which they shared the deve

Fosun International receives Sustainable Asia Award and Best Corporate Communications AwardOn 31 May 2024, themagazineCorporate Governance Asiapresented the 14th Asian Excellence Award. Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International Limited (“Fosun International”or “Fosun”or the “Group”) (HKEX stock code: 00656) were both

[Hong Kong –May 31, 2024] Fosun International Securities Limited(hereafter “Fosun International Securities”), subsidiary of Fosun Wealth International Holdings Limited(hereafter "Fosun Wealth Holdings"),has received preliminary approvalfromthe Securities and Futures Commissionof Hong Kong("SFC")to provide virtual asset dealing services. This impor

On 23 May, the “Invest in Shanghai, Sharethe Future” Overseas Promotion Campaign (New York, U.S.) was successfully heldin New York. Shanghai Mayor Gong Zheng delivered a keynote speech at thepromotion event, said, “Shanghai is speeding up the process of building itselfinto an international center of economy, finance, trade, shipping, andtechnologica

Shanghai, China & JERSEYCITY, N.J. – May 24, 2024 – Shanghai Henlius Biotech, Inc. (2696.HK) andOrganon (NYSE: OGN) today announced that the European Medicines Agency (EMA)has validated the marketing authorization applications (MAAs) for HLX14, aninvestigational Prolia^®and Xgeva^®(denosumab)biosimilar. Denosumab has been approved in various countries and regi

The 4th BEYOND International Technology Innovation Expo (BEYOND Expo 2024) commenced with a spectacular opening ceremony on 22 May at the Venetian Theatre in the Venetian Macao. At the opening ceremony, Guo Guangchang, Chairman of Fosun International, said that Fosun will steadfastly take innovation and globalization as the core drivers for its development in the next 30 ye

On 22 May 2024, Guo Guangchang, Chairman of Fosun International and his delegation met Ho Iat Seng, Chief Executive of Macao Special Administrative Region of the PRC (Macao SAR). Guo Guangchang provided an update on Fosun's business development in Macao SAR. Li Haifeng, Chairman of Fosun Foundation, Wen Xiaodong, Chairman of Fosun Infrastructure G